David Cullinane
Ceist:345. Deputy David Cullinane asked the Minister for Health the reason pluvicto was not approved for reimbursement but luthathera received approval; and if she will make a statement on the matter. [10724/26]
Amharc ar fhreagraDáil Éireann Debate, Wednesday - 11 February 2026
345. Deputy David Cullinane asked the Minister for Health the reason pluvicto was not approved for reimbursement but luthathera received approval; and if she will make a statement on the matter. [10724/26]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.